Data from The Cancer Genome Atlas suggest lung adenomas with high NQO1 (a downstream target of NRF2 and surrogate for NRF2 activation) mRNA expression exhibit immunosuppressive phenotypes with lower representation of genes relating to immune subsets [29,30]. The gene discussed is NFE2L2; the disease is lung adenoma.